CHAMPIONS ONCOLOGY, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Champions Oncology, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2012 to Q1 2024.
  • Champions Oncology, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending April 30, 2024 was $18.1M, a 8.06% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $18.1M +$1.35M +8.06% Apr 30, 2024 10-K 2024-07-19
Q1 2023 $16.8M +$1.25M +8.09% Apr 30, 2023 10-K 2024-07-19
Q1 2022 $15.5M +$161K +1.05% Apr 30, 2022 10-K 2023-07-24
Q1 2021 $15.3M -$119K -0.77% Apr 30, 2021 10-K 2022-07-22
Q1 2020 $15.5M +$507K +3.39% Apr 30, 2020 10-K 2021-07-26
Q1 2019 $15M +$544K +3.78% Apr 30, 2019 10-K 2020-07-28
Q1 2018 $14.4M -$7.37M -33.8% Apr 30, 2018 10-K 2019-07-29
Q1 2017 $21.8M +$2.71M +14.2% Apr 30, 2017 10-K 2018-07-30
Q1 2016 $19.1M +$3.86M +25.4% Apr 30, 2016 10-K 2017-07-28
Q1 2015 $15.2M +$4.24M +38.7% Apr 30, 2015 10-K 2016-07-29
Q1 2014 $11M +$2.02M +22.6% Apr 30, 2014 10-K 2015-07-29
Q1 2013 $8.95M +$2.58M +40.4% Apr 30, 2013 10-K 2014-07-28
Q1 2012 $6.37M Apr 30, 2012 10-K 2013-07-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.